0001769029-19-000001.txt : 20190227 0001769029-19-000001.hdr.sgml : 20190227 20190227170944 ACCESSION NUMBER: 0001769029-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190227 DATE AS OF CHANGE: 20190227 EFFECTIVENESS DATE: 20190227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abfero Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001769029 IRS NUMBER: 811705490 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333743 FILM NUMBER: 19638737 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 7812667297 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET STREET 2: SUITE 353 CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001769029 Abfero Pharmaceuticals, Inc. 405 WALTHAM STREET SUITE 353 LEXINGTON MA MASSACHUSETTS 02421 7812667297 MASSACHUSETTS None None Corporation true 2016 Thomas X. Neenan 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Steven Burke 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Michael Penington 405 Waltham Street Suite 353 Lexington MA MASSACHUSETTS 02421 Director Biotechnology Decline to Disclose 06b false 2019-02-20 false true true false 50000 1000000 300000 700000 false 2 0 0 100000 true false Abfero Pharmaceuticals, Inc. \s\ Thomas X. Neenan Thomas X. Neenan President 2019-02-27